- Report
- June 2024
- 84 Pages
United Kingdom
From €3147EUR$3,500USD£2,698GBP
- Report
- June 2024
- 85 Pages
Vietnam
From €3147EUR$3,500USD£2,698GBP
- Report
- November 2023
- 180 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- October 2023
- 137 Pages
Asia Pacific
From €3596EUR$4,000USD£3,083GBP
- Report
- October 2023
- 188 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- August 2023
- 76 Pages
Israel
From €3147EUR$3,500USD£2,698GBP
- Report
- February 2025
- 80 Pages
Europe
From €3596EUR$4,000USD£3,083GBP
- Report
- August 2024
- 85 Pages
India
From €3147EUR$3,500USD£2,698GBP
- Report
- July 2025
- 81 Pages
Africa, Middle East
From €3102EUR$3,450USD£2,659GBP
- Report
- July 2025
- 197 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- March 2025
- 111 Pages
Global
From €2652EUR$2,950USD£2,274GBP
- Report
- March 2025
- 78 Pages
North America
From €2652EUR$2,950USD£2,274GBP
- Report
- January 2025
- 111 Pages
Europe
From €3102EUR$3,450USD£2,659GBP
- Report
- January 2024
- 165 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- November 2024
- 99 Pages
Europe
From €3102EUR$3,450USD£2,659GBP
- Report
- April 2025
- 210 Pages
Europe
From €3147EUR$3,500USD£2,698GBP
- Report
- January 2025
- 180 Pages
Global
From €4491EUR$4,995USD£3,850GBP
- Report
- September 2024
- 300 Pages
Global
From €4491EUR$4,995USD£3,850GBP
- Report
- August 2024
- 400 Pages
Global
From €4491EUR$4,995USD£3,850GBP
- Report
- June 2024
- 172 Pages
Global
From €4491EUR$4,995USD£3,850GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more